Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

ViiV Healthcare

- PMLiVE

ViiV wins European approval for Tivicay

HIV treatment licensed in combination with other anti-retroviral drugs

- PMLiVE

This month in 2000: The formation of GSK

The twenty-first century’s first ‘mega merger’

- PMLiVE

GSK launches Facebook weight loss campaign for Alli

‘60-Day Kickstart’ initiative offers free healthy living support

- PMLiVE

GSK ends muscular dystrophy deal

Terminates rare disease collaboration with Prosensa after trial disappointment

- PMLiVE

FDA approves GSK’s combo cancer treatment

US regulator backs Mekinist and Tafinlar to treat melanoma

- PMLiVE

J&J’s Imbruvica tops Arzerra in phase III trial

Shows improvement over GSK’s drug in haematological malignancies

- PMLiVE

GSK’s Anoro first LAMA/LABA approved for COPD in US

Important step towards eventually replacing Seretide/Advair sales

- PMLiVE

No more sales targets for GSK reps

Pharma company will also stop direct payments to doctors

- PMLiVE

GSK increases stake in Indian pharma operations

Ups share holding in its Indian subsidiary

- PMLiVE

GSK invests £200m in UK medicine manufacturing

Will upgrade two sites and build centre for manufacturing innovation

- PMLiVE

Takeda appoints GSK’s Weber as chief operating officer

Could take on CEO role next year

- PMLiVE

CHMP backs shorter Cervarix schedule

Revised dosing could make running immunisation programmes with GSK's vaccine easier

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links